Form 8-K - Current report:
SEC Accession No. 0001558370-24-013273
Filing Date
2024-10-15
Accepted
2024-10-15 07:09:08
Documents
15
Period of Report
2024-10-15
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgtx-20241015x8k.htm   iXBRL 8-K 52427
2 EX-99.1 mgtx-20241015xex99d1.htm EX-99.1 32169
3 GRAPHIC mgtx-20241015xex99d1002.jpg GRAPHIC 3029
  Complete submission text file 0001558370-24-013273.txt   221729

Data Files

Seq Description Document Type Size
4 EX-101.SCH mgtx-20241015.xsd EX-101.SCH 3123
5 EX-101.LAB mgtx-20241015_lab.xml EX-101.LAB 15930
6 EX-101.PRE mgtx-20241015_pre.xml EX-101.PRE 10055
17 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20241015x8k_htm.xml XML 4911
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38520 | Film No.: 241369236
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)